What is Albemarle Corp's earnings per share (EPS)?

Albemarle Corp (ALB) reported diluted earnings per share of $-5.76 for fiscal year 2025. This represents a 48.6% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Albemarle Corp Financials

ALB

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows Albemarle Corp (ALB) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 18 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial Profile 38/100

Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability

Albemarle Corp has an operating margin of -7.1%, meaning the company retains $-7 of operating profit per $100 of revenue. This below-average margin results in a low score of 6/100, suggesting thin profitability after operating expenses. This is up from -33.0% the prior year.

Growth

Albemarle Corp's revenue declined 4.4% year-over-year, from $5.4B to $5.1B. This contraction results in a growth score of 26/100.

Leverage

Albemarle Corp carries a low D/E ratio of 0.33, meaning only $0.33 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 95/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

Albemarle Corp's current ratio of 2.23 indicates adequate short-term liquidity, earning a score of 41/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

Albemarle Corp has a free cash flow margin of 13.5%, earning a moderate score of 59/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

Albemarle Corp generates a -5.4% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100. This is up from -11.8% the prior year.

Piotroski F-Score Neutral

5/9

Albemarle Corp passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Mixed

-2.51x

For every $1 of reported earnings, Albemarle Corp generates $-2.51 in operating cash flow ($1.3B OCF vs -$510.6M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Interest Coverage At Risk

-1.8x

Albemarle Corp earns $-1.8 in operating income for every $1 of interest expense (-$367.1M vs $207.7M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$5.1B

YoY-4.4%

5Y CAGR+10.4%

10Y CAGR+6.2%

Albemarle Corp generated $5.1B in revenue in fiscal year 2025. This represents a decrease of 4.4% from the prior year.

EBITDA

$291.6M

YoY+124.5%

5Y CAGR-16.9%

10Y CAGR-7.0%

Albemarle Corp's EBITDA was $291.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 124.5% from the prior year.

Net Income

-$510.6M

YoY+56.7%

Albemarle Corp reported -$510.6M in net income in fiscal year 2025. This represents an increase of 56.7% from the prior year.

EPS (Diluted)

$-5.76

YoY+48.6%

Albemarle Corp earned $-5.76 per diluted share (EPS) in fiscal year 2025. This represents an increase of 48.6% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$692.5M

YoY+169.8%

10Y CAGR+17.9%

Albemarle Corp generated $692.5M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 169.8% from the prior year.

Cash & Debt

$1.6B

YoY+35.7%

5Y CAGR+16.7%

10Y CAGR+22.4%

Albemarle Corp held $1.6B in cash against $3.1B in long-term debt as of fiscal year 2025.

Dividends Per Share

$1.62

YoY+0.6%

5Y CAGR+1.0%

10Y CAGR+3.4%

Albemarle Corp paid $1.62 per share in dividends in fiscal year 2025. This represents an increase of 0.6% from the prior year.

Shares Outstanding

118M

YoY+0.2%

5Y CAGR+0.2%

10Y CAGR+0.5%

Albemarle Corp had 118M shares outstanding in fiscal year 2025. This represents an increase of 0.2% from the prior year.

Margins & Returns

Gross Margin

13.0%

YoY+11.8pp

5Y CAGR-18.8pp

10Y CAGR-17.4pp

Albemarle Corp's gross margin was 13.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 11.8 percentage points from the prior year.

Operating Margin

-7.1%

YoY+25.9pp

5Y CAGR-23.3pp

10Y CAGR-19.4pp

Albemarle Corp's operating margin was -7.1% in fiscal year 2025, reflecting core business profitability. This is up 25.9 percentage points from the prior year.

Net Margin

-9.9%

YoY+12.0pp

5Y CAGR-21.9pp

10Y CAGR-21.8pp

Albemarle Corp's net profit margin was -9.9% in fiscal year 2025, showing the share of revenue converted to profit. This is up 12.0 percentage points from the prior year.

Return on Equity

-5.4%

YoY+6.5pp

5Y CAGR-14.2pp

10Y CAGR-15.7pp

Albemarle Corp's ROE was -5.4% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 6.5 percentage points from the prior year.

Capital Allocation

R&D Spending

$51.4M

YoY-40.7%

5Y CAGR-2.8%

10Y CAGR-5.4%

Albemarle Corp invested $51.4M in research and development in fiscal year 2025. This represents a decrease of 40.7% from the prior year.

Share Buybacks

N/A

Capital Expenditures

$589.8M

YoY-64.9%

5Y CAGR-7.1%

10Y CAGR+10.0%

Albemarle Corp invested $589.8M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 64.9% from the prior year.

ALB Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$5.1B-4.4%	$5.4B-44.1%	$9.6B+31.4%	$7.3B+120.0%	$3.3B+6.4%	$3.1B
Cost of Revenue	$4.5B-15.8%	$5.3B-37.0%	$8.4B+98.6%	$4.2B+82.2%	$2.3B+9.2%	$2.1B
Gross Profit	$668.7M+969.3%	$62.5M-94.7%	$1.2B-61.4%	$3.1B+208.1%	$998.0M+0.3%	$994.9M
R&D Expenses	$51.4M-40.7%	$86.7M+1.2%	$85.7M+19.1%	$72.0M+33.2%	$54.0M-8.8%	$59.2M
SG&A Expenses	$550.0M-11.0%	$618.0M-32.1%	$910.0M+73.6%	$524.1M+18.7%	$441.5M+2.7%	$429.8M
Operating Income	-$367.1M+79.3%	-$1.8B-805.3%	$251.9M-89.8%	$2.5B+209.4%	$798.4M+57.9%	$505.8M
Interest Expense	$207.7M+25.4%	$165.6M+42.7%	$116.1M-5.6%	$123.0M+100.0%	$61.5M-15.9%	$73.1M
Income Tax	$156.9M+80.1%	$87.1M-79.8%	$430.3M+10.2%	$390.6M+1226.5%	$29.4M-45.9%	$54.4M
Net Income	-$510.6M+56.7%	-$1.2B-175.0%	$1.6B-41.5%	$2.7B+2075.0%	$123.7M-67.1%	$375.8M
EPS (Diluted)	$-5.76+48.6%	$-11.20-183.8%	$13.36-41.5%	$22.84+2054.7%	$1.06-69.9%	$3.52

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Revenue	$1.4B+9.2%	$1.3B-1.7%	$1.3B+23.5%	$1.1B-12.6%	$1.2B-9.1%	$1.4B-5.3%	$1.4B+5.1%	$1.4B
Cost of Revenue	$1.2B+3.4%	$1.2B+5.0%	$1.1B+23.1%	$920.6M-15.8%	$1.1B-25.0%	$1.5B+1.2%	$1.4B+9.0%	$1.3B
Gross Profit	$197.9M+68.3%	$117.6M-40.3%	$196.9M+26.0%	$156.3M+13.1%	$138.2M+232.9%	-$104.0M-883.5%	-$10.6M-127.2%	$38.9M
R&D Expenses	$12.2M-3.9%	$12.7M+1.8%	$12.4M-11.7%	$14.1M-29.6%	$20.0M-10.6%	$22.4M+7.8%	$20.8M-11.7%	$23.5M
SG&A Expenses	$155.5M+12.2%	$138.6M+4.6%	$132.5M+7.3%	$123.5M-9.2%	$136.0M-11.8%	$154.3M-7.3%	$166.4M+3.1%	$161.4M
Operating Income	-$217.4M-0.2%	-$217.0M-556.6%	$47.5M+140.5%	$19.8M+348.9%	$4.4M+100.4%	-$1.1B-125.1%	-$492.6M-174.4%	-$179.5M
Interest Expense	$57.8M+13.4%	$51.0M+2.0%	$49.9M+2.0%	$49.0M+9.6%	$44.7M-6.4%	$47.8M+35.7%	$35.2M-7.3%	$38.0M
Income Tax	$157.3M+614.7%	-$30.6M-189.6%	$34.1M+957.1%	-$4.0M-137.5%	$10.6M-90.4%	$110.9M+461.6%	-$30.7M-724.0%	-$3.7M
Net Income	-$414.2M-157.7%	-$160.7M-801.8%	$22.9M-44.6%	$41.3M-45.1%	$75.3M+107.0%	-$1.1B-468.0%	-$188.2M-7787.8%	$2.4M
EPS (Diluted)	N/A	$-1.72-975.0%	$-0.16	$0.00	N/A	$-9.45-382.1%	$-1.96-2350.0%	$-0.08

ALB Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$16.4B-1.4%	$16.6B-9.1%	$18.3B+18.2%	$15.5B+40.8%	$11.0B+5.0%	$10.5B
Current Assets	$4.0B+4.3%	$3.8B-26.3%	$5.2B+0.6%	$5.2B+160.2%	$2.0B-9.6%	$2.2B
Cash & Equivalents	$1.6B+35.7%	$1.2B+34.0%	$889.9M-40.6%	$1.5B+241.3%	$439.3M-41.2%	$746.7M
Inventory	$1.2B-21.5%	$1.5B-30.5%	$2.2B+4.1%	$2.1B+160.0%	$798.6M+6.4%	$750.2M
Accounts Receivable	$593.5M-20.0%	$742.2M-38.8%	$1.2B+1.9%	$1.2B+113.8%	$556.9M+4.9%	$530.8M
Goodwill	$1.5B-5.2%	$1.6B-2.9%	$1.6B+0.7%	$1.6B+1.3%	$1.6B-4.1%	$1.7B
Total Liabilities	$6.8B+2.9%	$6.6B-25.0%	$8.9B+18.5%	$7.5B+39.7%	$5.3B-13.5%	$6.2B
Current Liabilities	$1.8B-8.6%	$2.0B-44.8%	$3.6B+29.9%	$2.7B+46.2%	$1.9B+4.0%	$1.8B
Long-Term Debt	$3.1B0.0%	$3.1B-11.9%	$3.5B+10.1%	$3.2B+60.4%	$2.0B-27.6%	$2.8B
Total Equity	$9.5B-4.3%	$10.0B+5.8%	$9.4B+17.9%	$8.0B+41.9%	$5.6B+31.8%	$4.3B
Retained Earnings	$4.6B-15.8%	$5.5B-21.5%	$7.0B+24.7%	$5.6B+80.9%	$3.1B-1.9%	$3.2B

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Total Assets	$16.4B-4.5%	$17.1B-0.8%	$17.3B+1.7%	$17.0B+2.3%	$16.6B-4.8%	$17.5B-5.1%	$18.4B-3.4%	$19.0B
Current Assets	$4.0B-12.0%	$4.6B+1.1%	$4.5B+9.7%	$4.1B+6.9%	$3.8B-17.7%	$4.7B-10.6%	$5.2B-10.3%	$5.8B
Cash & Equivalents	$1.6B-16.2%	$1.9B+6.9%	$1.8B+19.0%	$1.5B+27.4%	$1.2B-28.4%	$1.7B-9.1%	$1.8B-11.0%	$2.1B
Inventory	$1.2B-23.1%	$1.5B-6.6%	$1.6B-0.9%	$1.7B+10.2%	$1.5B-9.4%	$1.7B-7.9%	$1.8B-5.5%	$1.9B
Accounts Receivable	$593.5M-19.1%	$733.5M-4.3%	$766.4M+14.3%	$670.8M-9.6%	$742.2M-1.0%	$749.8M-4.6%	$785.6M-10.1%	$874.0M
Goodwill	$1.5B+0.6%	$1.5B-10.8%	$1.7B+4.0%	$1.6B+1.5%	$1.6B-3.4%	$1.6B+2.3%	$1.6B-0.8%	$1.6B
Total Liabilities	$6.8B-4.4%	$7.2B+1.4%	$7.1B+1.2%	$7.0B+4.9%	$6.6B-7.9%	$7.2B+0.7%	$7.2B-4.5%	$7.5B
Current Liabilities	$1.8B-10.3%	$2.0B+2.8%	$1.9B+0.3%	$1.9B-1.1%	$2.0B+2.9%	$1.9B-2.4%	$2.0B-4.5%	$2.1B
Long-Term Debt	$3.1B-1.9%	$3.2B+0.1%	$3.2B+1.6%	$3.1B+0.3%	$3.1B-12.6%	$3.6B+1.3%	$3.5B0.0%	$3.5B
Total Equity	$9.5B-4.6%	$10.0B-2.4%	$10.2B+2.1%	$10.0B+0.7%	$10.0B-2.7%	$10.2B-8.7%	$11.2B-2.7%	$11.5B
Retained Earnings	$4.6B-9.8%	$5.1B-4.7%	$5.4B-1.2%	$5.4B-0.9%	$5.5B-0.3%	$5.5B-17.4%	$6.7B-4.0%	$6.9B

ALB Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$1.3B+86.4%	$687.9M-48.1%	$1.3B-30.6%	$1.9B+455.5%	$344.3M-56.9%	$798.9M
Capital Expenditures	$589.8M-64.9%	$1.7B-22.0%	$2.2B+70.8%	$1.3B+32.3%	$953.7M+12.1%	$850.5M
Free Cash Flow	$692.5M+169.8%	-$992.7M-19.9%	-$828.0M-227.2%	$650.8M+206.8%	-$609.4M-1081.9%	-$51.6M
Investing Cash Flow	-$146.0M+90.8%	-$1.6B+38.2%	-$2.6B-76.4%	-$1.5B-118.1%	-$666.6M+22.8%	-$863.6M
Financing Cash Flow	-$834.2M-167.2%	$1.2B+99.0%	$623.9M+2.0%	$611.9M+1118.6%	$50.2M-71.7%	$177.3M
Dividends Paid	$190.5M+1.1%	$188.5M+0.7%	$187.2M+1.5%	$184.4M+3.7%	$177.9M+9.9%	$161.8M
Share Buybacks	N/A	N/A	N/A	N/A	N/A	$0

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Operating Cash Flow	$388.5M+9.2%	$355.6M+4039.3%	-$9.0M-101.6%	$547.2M+12596.2%	-$4.4M-101.9%	$227.1M-38.2%	$367.7M+277.1%	$97.5M
Capital Expenditures	$155.4M+17.6%	$132.2M+10.5%	$119.6M-34.5%	$182.6M-46.7%	$342.8M+13.1%	$303.1M-32.9%	$451.6M-22.6%	$583.0M
Free Cash Flow	$233.1M+4.3%	$223.4M+273.7%	-$128.7M-135.3%	$364.6M+205.0%	-$347.2M-356.7%	-$76.0M+9.4%	-$83.9M+82.7%	-$485.6M
Investing Cash Flow	-$176.6M-15.5%	-$153.0M-148.9%	$312.7M+342.3%	-$129.1M+60.7%	-$328.5M-3.6%	-$317.1M+30.9%	-$459.2M+4.3%	-$480.0M
Financing Cash Flow	-$533.0M-488.8%	-$90.5M+0.1%	-$90.6M+24.5%	-$120.0M-29.2%	-$92.9M+15.5%	-$110.0M+2.4%	-$112.7M-107.2%	$1.6B
Dividends Paid	$47.6M-0.1%	$47.7M0.0%	$47.6M+0.1%	$47.6M0.0%	$47.6M+1.3%	$47.0M0.0%	$47.0M+0.2%	$46.9M
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

ALB Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	13.0%+11.8pp	1.2%-11.2pp	12.3%-29.7pp	42.0%+12.0pp	30.0%-1.8pp	31.8%
Operating Margin	-7.1%+25.9pp	-33.0%-35.7pp	2.6%-31.1pp	33.7%+9.7pp	24.0%+7.8pp	16.2%
Net Margin	-9.9%+12.0pp	-21.9%-38.3pp	16.4%-20.4pp	36.8%+33.0pp	3.7%-8.3pp	12.0%
Return on Equity	-5.4%+6.5pp	-11.8%-28.6pp	16.7%-17.0pp	33.7%+31.5pp	2.2%-6.6pp	8.8%
Return on Assets	-3.1%+4.0pp	-7.1%-15.7pp	8.6%-8.8pp	17.4%+16.3pp	1.1%-2.5pp	3.6%
Current Ratio	2.23+0.3	1.95+0.5	1.47-0.4	1.89+0.8	1.06-0.2	1.22
Debt-to-Equity	0.33+0.0	0.31-0.1	0.38-0.0	0.40+0.0	0.36-0.3	0.65
FCF Margin	13.5%+31.9pp	-18.5%-9.8pp	-8.6%-17.5pp	8.9%+27.2pp	-18.3%-16.7pp	-1.7%

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Gross Margin	13.9%+4.9pp	9.0%-5.8pp	14.8%+0.3pp	14.5%+3.3pp	11.2%+18.9pp	-7.7%-6.9pp	-0.7%-3.6pp	2.9%
Operating Margin	-15.2%+1.4pp	-16.6%-20.2pp	3.6%+1.7pp	1.8%+1.5pp	0.4%+82.2pp	-81.8%-47.4pp	-34.4%-21.3pp	-13.2%
Net Margin	-29.0%-16.7pp	-12.3%-14.0pp	1.7%-2.1pp	3.8%-2.3pp	6.1%+85.0pp	-78.9%-65.8pp	-13.2%-13.3pp	0.2%
Return on Equity	-4.3%-2.7pp	-1.6%-1.8pp	0.2%-0.2pp	0.4%-0.3pp	0.8%+11.2pp	-10.4%-8.8pp	-1.7%-1.7pp	0.0%
Return on Assets	-2.5%-1.6pp	-0.9%-1.1pp	0.1%-0.1pp	0.2%-0.2pp	0.4%+6.6pp	-6.1%-5.1pp	-1.0%-1.0pp	0.0%
Current Ratio	2.23-0.0	2.27-0.0	2.31+0.2	2.11+0.2	1.95-0.5	2.44-0.2	2.67-0.2	2.84
Debt-to-Equity	0.330.0	0.320.0	0.310.0	0.310.0	0.31-0.0	0.35+0.0	0.310.0	0.31
FCF Margin	16.3%-0.8pp	17.1%+26.8pp	-9.7%-43.5pp	33.9%+62.1pp	-28.2%-22.6pp	-5.6%+0.3pp	-5.9%+29.8pp	-35.7%

Similar Companies

Eastman Chem Co EMN

$8.6B

Newmarket NEU

$6.0B

Axalta Coating Sys Ltd AXTA

$5.7B

Element Solutions Inc ESI

$8.3B

Sasol SSL

$7.9B

Frequently Asked Questions

What is Albemarle Corp's annual revenue?

Albemarle Corp (ALB) reported $5.1B in total revenue for fiscal year 2025. This represents a -4.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Albemarle Corp's revenue growing?

Albemarle Corp (ALB) revenue declined by 4.4% year-over-year, from $5.4B to $5.1B in fiscal year 2025.

Is Albemarle Corp profitable?

No, Albemarle Corp (ALB) reported a net income of -$510.6M in fiscal year 2025, with a net profit margin of -9.9%.

What is Albemarle Corp's EBITDA?

Albemarle Corp (ALB) had EBITDA of $291.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Albemarle Corp have?

As of fiscal year 2025, Albemarle Corp (ALB) had $1.6B in cash and equivalents against $3.1B in long-term debt.

What is Albemarle Corp's gross margin?

Albemarle Corp (ALB) had a gross margin of 13.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Albemarle Corp's operating margin?

Albemarle Corp (ALB) had an operating margin of -7.1% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Albemarle Corp's net profit margin?

Albemarle Corp (ALB) had a net profit margin of -9.9% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Albemarle Corp pay dividends?

Yes, Albemarle Corp (ALB) paid $1.62 per share in dividends during fiscal year 2025.

What is Albemarle Corp's return on equity (ROE)?

Albemarle Corp (ALB) has a return on equity of -5.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Albemarle Corp's free cash flow?

Albemarle Corp (ALB) generated $692.5M in free cash flow during fiscal year 2025. This represents a 169.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Albemarle Corp's operating cash flow?

Albemarle Corp (ALB) generated $1.3B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Albemarle Corp's total assets?

Albemarle Corp (ALB) had $16.4B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Albemarle Corp's capital expenditures?

Albemarle Corp (ALB) invested $589.8M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Albemarle Corp spend on research and development?

Albemarle Corp (ALB) invested $51.4M in research and development during fiscal year 2025.

How many shares does Albemarle Corp have outstanding?

Albemarle Corp (ALB) had 118M shares outstanding as of fiscal year 2025.

What is Albemarle Corp's current ratio?

Albemarle Corp (ALB) had a current ratio of 2.23 as of fiscal year 2025, which is generally considered healthy.

What is Albemarle Corp's debt-to-equity ratio?

Albemarle Corp (ALB) had a debt-to-equity ratio of 0.33 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Albemarle Corp's return on assets (ROA)?

Albemarle Corp (ALB) had a return on assets of -3.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Albemarle Corp's Piotroski F-Score?

Albemarle Corp (ALB) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Albemarle Corp's earnings high quality?

Albemarle Corp (ALB) has an earnings quality ratio of -2.51x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Albemarle Corp cover its interest payments?

Albemarle Corp (ALB) has an interest coverage ratio of -1.8x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Albemarle Corp?

Albemarle Corp (ALB) scores 38 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.